Article
% IGHD of B−cells
Non−responderResponder
IGHD P = 0.19
% IGHG of B−cells
IGHG P = 0.56
0
1
2
3
4
Iliac lymph node Axillary lymph nodeAxillary lymph nodeAxillary lymph node External iliac lymph node Acral primary SpleenTerminal Ileum Cutanoues met Axillary lymph nodeAxillary lymph nodeSubcutaneous leg lesionSmall bowel Adrenal gland metastasisBulky (L) axillary metastasis SkinNecrotic L axillary lymph nodesLymph nodeLymph nodeR adrenal metastasisTransanal rectal massSoft tissueSkinSkinSkinSkinLymph node
Mel94Mel79Mel80Mel89Mel72Mel84Mel60Mel74Mel88Mel82Mel81Mel58Mel78Mel102Mel112Mel105Mel106Mel103Mel116Mel110Mel478Mel126
Mel129pbMel129paMel121
Mel04Mel128
Activated B cellImmature B cell
Memory B cellPlasmacellUP_BcellDN
a.
012 3 456
Plasma cells
IGLL1/5-/CD69-
IGLL1/5-/CD69+
IGLL1/5+/CD69-
IGLL1/5+/CD69+
Absolute expr.
% CD69+ B cells
Non−responderResponder
CD69, P = 0.0037
0
20
40
60
80
100
% IGLL5+ B cells
IGLL5, P = 0.17
0
10
20
30
40
50
Non−responderResponder
IGLL5-/CD69+,
P = 0.0098
Non−responderResponder
% IGLL5-/CD69+ B cells
0
20
40
60
80
100
anti-CTLA4
anti-CTLA4+PD1
anti-PD1
BACH2
MEF2BMYC
MEF2CPOU2AF1
IRF4
CCND2CD19
AIM2FCER2
TCL1AREL
EZH2ICOSLG
CD40MS4A1
XBP1JAM3
NOTCH2CD83
PDCD1CD86
CXCR4LAMP3
SELLCXCR5
CCR7CXCL13
CCL21CCL19
HLA−BHLA−A
CD74Mean_HLAD
HLA−DRAMKI67
IGLL1IGLL5
JUNBNR4A2
FOSCD69
DZLZ
AICDABCL6
PRDM1SDC1
PlasmacellUP_BcellDNMemory B cell
Immature B cellActivated B cell
Tumor
Mel04.3
Mel102Mel103
Mel105
Mel106Mel110
Mel112
Mel116Mel121.1
Mel126
Mel128Mel129pa
Mel129pb
Mel478Mel58
Mel60
Mel72Mel74
Mel78
Mel79Mel80
Mel81Mel82
Mel84Mel88
Mel89
Mel94^0
20
40
60
80
100
0
20
40
60
80
100
Non−responderResponder
CCND3
HLA−C
TLS hallmark
genes
GC initiation
genes
GC genes
DZ proliferation
B cell related
genes
Tumors
b.
c.
CD79B
CD1D
CCR6
LAT
SKAP1
CETP
EIF1AY
RBP5
PTGDS
BACH2 % IGHG^2
GCgenes initiation (^4)
CCL19
CCL21
CXCL13
CCR7
CXCR5
SELL (CD62L)
LAMP3
0246810
02468
CD69
CD83
0246810
0246810
CD69
CXCR4
CD69-
CD69+
CD83+
CD83-
CD83+
CD83-
P = 1.4x10-8
correlation = 0.31
CD69-
CD69+
CXCR4+
CXCR4-
CXCR4-
CXCR4+
P = 2.6x10-6
correlation = 0.37
d.
e. f.
Extended Data Fig. 3 | scRNA-seq analysis of tumour-associated B cells.
a, Box plots of gene-expression scores, based on different B cell developmental
states in 812 B cells from 27 tumours from a previous study^18. b, Heat map of
selected genes across all 812 B cells. IGLL5and CD69 were two of the five genes
with highest expression variation across all B cells. The heat map is sorted on
IGLL5 and CD69 expression, excluding the cells that displayed increased
expression of the plasma-cell signature. Genes showing a Pearson correlation
0.4 to IGLL5 or CD69 expression are also indicated. SDC1 and PRDM1 mark
plasma cells, BCL6 and AICDA mark germinal centres, HLA-DRA mark MHC-II
and HLA-A, HLA-B and HLA-C mark MHC-I. TL S-hallmark genes, germinal-
centre-related genes and other B cell genes are also indicated. c, Extracting the
single B cell RNA-seq data from a previous study^17 using pretreatment samples
(n = 16). The fraction of CD69+ B cells was higher in responders to ICB than in
nonresponders (n = 8), but the fraction of IGLL5+ B cells was not. The fraction of
IGLL5− CD69+ cells was also higher in responders. Plots of fraction of IGHD+ and
IGHG+ B cells in relation to response to ICB therapy. P values from two-sided
Wilcoxon test. In a, the centre lines in the box plot represent the median, the
box limits represent the lower and upper quartiles, and the whiskers extend to
the most extreme values within 1.5× IQR. d, Pearson correlation between
expression of CD69 and germinal centre genes (CD83 and CXCR4) in data from a
previous study^18. Pie charts display the fact that the fraction of CD83+ and
CXCR4+ B cells is increased among CD69+ B cells. Expression > 1 was used as a
cut-off for being present. Seven hundred and fifty-three B cells without a
present plasma-cell signature were analysed. P value from two-sided Fisher’s
exact test. e, f, Heat map of gene-expression values corresponding to our TLS
signature (e) and TLS-hallmark genes from the literature (f). Blue corresponds
to increased expression. Mal., malignant cells. In e, f, single cells from the seven
cell types on the left are from ref.^18 , and from the four cell types on the right are
from ref.^17.